Optimising Prostate Cancer Diagnostics
Date: 29 – 30 September 2015
Robens Suite, Guy’s Hospital, London SE1 9RT
This highly practical two-day course provides an update on the use of mp MRI transperineal and transrectal biopsies in prostate diagnostics. There has been increasing interest in carrying out transperineal prostate mapping biopsies for the assessment of patients with negative TRUS biopsies to better select patients for Active Surveillance and to risk stratify patients with equivocal disease.
However, the diagnostic paradigm is changing with the use of MRI prior to biopsy and the introduction of MR fusion-targeted biopsies, but there is still a need to systematically biopsy the apparently normal prostate. At Guy’s Hospital we have developed a systematic transperineal sector biopsy protocol, which preferentially targets the peripheral zone with fewer cores than template mapping protocols and less morbidity. Over the last 24 months we have incorporated MR US-Fusion biopsies in our diagnostic and targeted treatment protocols.
Mr Rick Popert, Consultant Urologist, Guy’s and St Thomas’
Mr Ben Challacombe, Consultant Urologist, Guy’s and St Thomas’
Mr Paul Cathcart, Consultant Urologist, Guy’s and St Thomas’
12 CPD points have been accredited from the British Association of Urological Surgeons. (6 CPD points per day)
Who should attend?
The masterclass is specifically designed for health professionals that work directly with prostate cancer diagnosis and TP biopsies. This means that consultants, registrars, nurse practitioners, pathologists, radiologists and theatre nurses are all encouraged to attend.
The number of available places is limited due to the masterclass involving practical sessions; therefore we strongly advise that you book your place as early as possible.